Abiopharma

🔍 Foster Karen A. (Executive)

Company: BIOLIFE SOLUTIONS INC (BLFS)

Report Date: 2026-03-05

Detailed Transactions and Holdings:

• Sold 96,923 shares of Common Stock at $20.15 per share (Direct)
  Date: 2026-03-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 113,742.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 500 shares of Common Stock at $20.0 per share (Direct)
  Date: 2026-03-09 | Code: S | equity_swap_involved: 0 | shares_owned_after: 113,242.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.46, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.02, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.